IGF1 and gastric cancer: To further investigate the effects of DSC2 on the PI3K/AKT signaling pathway in GC cells, MGC-803 and SGC-7901 cells were pretreated with PI3K inhibitor, LY294002 (30 μM), and its activator, IGF1 (20 μM), for 24 h or 48 h.